Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
Legumain is highly expressed in prostate cancer and other solid tumors and is a potential anticancer target. Here we investigated the role of legumain in invasion and metastasis in prostate cancer cell lines. In vitro invasion assay did not show significant difference in invasive ability regardless of legumain expression level. In addition, hypoxic condition did not change legumain mRNA expression in prostate cancer cells. Therefore, we need experiment under chronic hypoxic condition and established hypoxia resistant prostate cancer cell line by continuous cultivation over 6 months. Legumain expression on mRNA level in hypoxia resistant cell lines was higher than that in parental cell lines. We have a plan of further study.
|